RANDOMIZED TRIAL OF ASPIRIN AS ADJUVANT THERAPY FOR NODE-POSITIVE BREAST CANCER

$11,511,610FY2015Department of the ArmyDOD

Brigham & Womens Hospital Inc

Investigators

View source on USAspending →